The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine
Journal Title: Sultan Qaboos University Medical Journal - Year 2011, Vol 11, Issue 2
Abstract
Pharmacokinetics, pharmacodynamics and pharmacogenetics play an important role in drug discovery and contribute to treatment success. Tis is an essential issue in cancer treatment due to its high toxicity. During the last decade, cyclin-dependent kinase inhibitors were recognised as a new class of compounds that was introduced for the treatment of several diseases including cancer. Cyclin-dependent kinases (Cdks) play a key role in the regulation of cell cycle progression and ribonucleic acid transcription. Deregulation of Cdks has been associated with several malignancies, neurodegenerative disorders, viral and protozoa infections, glomerulonephritis and inflammatory diseases. (R)-roscovitine is a synthetic tri-substituted purine that inhibits selectively Cdk1, 2, 5, 7 and 9. Roscovitine has shown promising cytotoxicity in cell lines and tumor xenografts. In this paper, we present several aspects of pharmacokinetics (PK) and pharmacodynamics (PD) of roscovitine. We present also some of our investigations including bioanalysis, haematotoxicity, age dependent kinetics, PK and effects on Cdks in the brain. Unfavourable kinetic parameters in combination with poor distribution to the bone marrow compartment could explain the absence of myelosuppression in vivo despite the efcacy in vitro.Higher plasma and brain exposure and longer elimination half-life found in rat pups compared to adult rats may indicate that roscovitine can be a potential candidate for the treatment of brain tumours in children. Cdk5 inhibition and Erk1/2 activation that was detected in brain of rat pups may suggest the use of roscovitine in neurodegenerative diseases. Early pharmacokinetic/pharmacodynamic studies are important issues in drug discovery and may affect further development of promising drug candidates.
Authors and Affiliations
Moustapha Hassan| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinical Research Centrum, Karolinska University Hospital, Huddinge, Stockholm, Sweden, Hatem Sallam| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Zuzana Hassan| Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinical Research Centrum, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Keywords
Related Articles
- EP ID EP14040
- DOI -
- Views 300
- Downloads 9
Insulin Resistance and its Correlation with Risk Factors for Developing Diabetes Mellitus in 100 Omani Medical Students
Objectives: Te aim of this study was to assess the prevalence of insulin resistance (IR) in healthy young Omanis and relate this with their body mass index (BMI) and family history (FH) of diabetes mellitus (DM). Metho...
Group A Streptococcal Pericarditis in a Four-Month-Old Infant Case report
Purulent pericarditis is uncommon among paediatric patients and cases caused by group A Streptococcus (GAS) are even rarer. We report a four-month-old female infant who was referred to the Royal Hospital, Muscat, Oman,...
A Possible Case of Systemic Lupus Erythematosus Presenting with Generalised Oedema
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology affecting various systems within the body. We report the case of a patient with generalised subcutaneous oedema as the only presenting f...
Seizures as an Atypical Feature of Beal’s Syndrome
Congenital contractural arachnodactyly, commonly known as Beal’s syndrome, is an extremely rare genetic disorder caused by mutations in the fbrillin-2 (FBN2) gene located on chromosome 5q23. It is an autosomal domina...
In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa
Objectives: Te coagulation cascade initiated during vascular injury prevents bleeding. Unwanted clot formation is however detrimental and requires the use of anticoagulants for prophylaxis and treatment. Anticoagulants...